AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(Full text of this release can be found at http:/www.asianetnews.net)
BRISBANE, Feb 27/MediaNet International-AsiaNet/ --
Further Encouragement for PI-88 from Avastins Approval
Progen Industries Limited (ASX: PGL, NASDAQ: PGLAF), a progressive Australian drug development company, today announced its half year financial results to December 31st, 2003 and said the company is on track to meet its objectives for 2004.
"Progen's operating loss for the half-year ending 31 December 2003 was $1,895,201. This is a good result ...